Does a 6-Month Multicomponent Training Improve Functional Capacity of Individuals With a Neurocognitive Disorder?
Author(s) -
Óscar Ribeiro,
Flávia BorgesMachado,
Duarte Barros,
Laetitia Teixeira,
Joana Carvalho
Publication year - 2021
Publication title -
innovation in aging
Language(s) - English
Resource type - Journals
ISSN - 2399-5300
DOI - 10.1093/geroni/igab046.3247
Subject(s) - neurocognitive , physical therapy , medicine , physical medicine and rehabilitation , activities of daily living , intervention (counseling) , balance (ability) , quality of life (healthcare) , psychology , cognition , psychiatry , nursing
Regular physical activity and exercise have been proposed as non-pharmacological therapeutic approaches to prevent and manage neurocognitive disorders (NCD). Multicomponent training (MT) combining aerobics, strength, postural and balance exercises seem to be effective at improving individuals with NCD in their ability to independently perform activities of daily living (ADL). This quasi-experimental controlled trial aims to analyze the effects of a 6-month MT intervention on functional capacity of individuals diagnosed with NCD. Forty-three subjects (N Major NCD: 36) participated in the Body&Brain Project and were subdivided in exercise group (EG; N: 23; 75.09 ± 5.65 years; age range: 61-83) or a control group (CG; N:20; 81.90 ± 5.95 years; age range: 70-89). The EG was submitted to bi-weekly exercise sessions, and the CG received monthly recreation sessions. At baseline and at post-intervention Timed-Up-and-Go (TUG), 6-meters Walk Speed and Handgrip tests were applied to evaluate lower body mobility, walking speed and handgrip strength, respectively. Results from linear mixed models revealed a statistically significant interaction between group (intervention vs. control) and time for TUG and walk speed test, but not for handgrip strength. The 6-month MT intervention improved lower body mobility and walking speed of older adults diagnosed with NCD, which might potentially impact ADL independence and quality of life. Trial registration: ClinicalTrials.gov - NCT04095962. Supported by FCT: “Body and Brain” (POCI-01-0145-FEDER-031808), CIAFEL (FCT/UIDB/00617/2020), and Ph.D. Grants (SFRH/BD/136635/2018) to FM and [2020.05911.BD] to DB.
Accelerating Research
Robert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom
Address
John Eccles HouseRobert Robinson Avenue,
Oxford Science Park, Oxford
OX4 4GP, United Kingdom